|
|
| |
|
|
|
|
| |
|
|
|
|
《盈警》思城控股預報上半年虧損最多1,500萬
2026-08-16T
|
《業績》思城控股全年純利2,643萬元 虧轉盈
2026-03-27T
|
《業績》思城控股中期純利5,083萬元 虧轉盈
2025-08-25T
|
《盈喜》思城控股料中期虧轉盈賺不少於5,000萬元
2025-08-18T
|
思城控股2,216.1萬股未獲認購供股股份全數配售
2025-06-19T
|
思城控股折讓67.21%供股 集資1,440萬元
2025-04-30T
|
《業績》思城控股全年虧損收窄至1,485.1萬元
2025-03-27T
|
《業績》思城控股中期虧損收窄至1,220萬元
2024-08-28T
|
《公司業績》思城控股全年虧損擴至2,124萬元
2024-03-27T
|
思城控股附屬投資內地醫用放射性同位素項目 涉資2,500萬人幣
2023-11-16T
|
|
|
|
Next page >
|
|
|
| Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.
|
|